| Non-Hodgkin Lymphoma by Clinical Course investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 154show all (up to 200) |
|---|
| → investigated in trials for | Rituximabmonoclonal antibody 194 trials (61 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 194 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 147 trials (53 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 147 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 89 trials (24 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 73 trials (25 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 70 trials (21 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 68 trials (29 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 64 trials (24 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 59 trials (24 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 46 trials (14 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 40 trials (18 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 39 trials (10 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 38 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 35 trials (12 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 34 trials (12 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 34 trials (16 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 34 | Observed | clinicaltrials | graph → |